Trial Profile
Evaluation of CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Saliva of Menstrual Migraine Patients Before and After Treatment With Treximet™
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Aug 2023
Price :
$35
*
At a glance
- Drugs Naproxen sodium/sumatriptan (Primary)
- Indications Menstrual migraine
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 06 May 2011 Actual initiation date (May 2011) added as reported by ClinicalTrials.gov.
- 06 May 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 08 Apr 2011 New trial record